Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Apple
AAPL
|
$5.83B |
| 2 |
Tesla
TSLA
|
$989M |
| 3 |
Zoom
ZM
|
$96M |
| 4 |
Match Group
MTCH
|
$81.3M |
| 5 |
Peloton Interactive
PTON
|
$75.6M |
Top Sells
| 1 |
Microsoft
MSFT
|
$112M |
| 2 |
Amazon
AMZN
|
$73.4M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$52.8M |
| 4 |
Oracle
ORCL
|
$45.8M |
| 5 |
Meta Platforms (Facebook)
META
|
$40.5M |
Sector Composition
| 1 | Technology | 26.26% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Communication Services | 10.36% |
| 5 | Industrials | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AT&T
T
$209B
| $853M | 0.67% | 29,934,837 -633,800 | -2% | -$18.1M |
|
27
Intel
INTC
$107B
| $853M | 0.67% | 16,480,804 -434,100 | -3% | -$22.5M |
|
28
Pfizer
PFE
$141B
| $848M | 0.66% | 23,100,991 -264,700 | -1% | -$9.71M |
|
29
Comcast
CMCSA
$125B
| $844M | 0.66% | 18,252,073 -239,900 | -1% | -$11.1M |
|
30
McDonald's
MCD
$224B
| $775M | 0.61% | 3,531,782 -53,800 | -2% | -$11.8M |
|
31
Abbott
ABT
$231B
| $774M | 0.6% | 7,107,608 -89,100 | -1% | -$9.7M |
|
32
Thermo Fisher Scientific
TMO
$186B
| $679M | 0.53% | 1,537,460 -39,800 | -3% | -$17.6M |
|
33
Cisco
CSCO
$274B
| $678M | 0.53% | 17,204,545 -271,600 | -2% | -$10.7M |
|
34
Accenture
ACN
$162B
| $646M | 0.51% | 2,858,238 -31,900 | -1% | -$7.21M |
|
35
NextEra Energy, Inc.
NEE
$148B
| $634M | 0.5% | 2,282,583 -28,800 | -1% | -$7.99M |
|
36
Costco
COST
$418B
| $630M | 0.49% | 1,776,018 -28,500 | -2% | -$10.1M |
|
37
Medtronic
MDT
$119B
| $607M | 0.47% | 5,840,354 -82,400 | -1% | -$8.56M |
|
38
Nike
NKE
$114B
| $606M | 0.47% | 4,826,761 -86,700 | -2% | -$10.9M |
|
39
Danaher
DHR
$147B
| $606M | 0.47% | 2,813,520 +3,700 | +0.1% | +$797K |
|
40
AbbVie
ABBV
$372B
| $602M | 0.47% | 6,874,891 -110,400 | -2% | -$9.67M |
|
41
Exxon Mobil
XOM
$487B
| $587M | 0.46% | 17,106,992 -279,900 | -2% | -$9.61M |
|
42
Amgen
AMGN
$155B
| $585M | 0.46% | 2,300,818 -31,800 | -1% | -$8.08M |
|
43
Eli Lilly
LLY
$657B
| $576M | 0.45% | 3,889,498 -51,400 | -1% | -$7.61M |
|
44
Broadcom
AVGO
$1.4T
| $573M | 0.45% | 1,572,513 -23,500 | -1% | -$8.56M |
|
45
Bristol-Myers Squibb
BMY
$96B
| $538M | 0.42% | 8,917,088 -120,900 | -1% | -$7.29M |
|
46
Chevron
CVX
$324B
| $525M | 0.41% | 7,298,250 -159,900 | -2% | -$11.5M |
|
47
Texas Instruments
TXN
$184B
| $525M | 0.41% | 3,676,654 -121,300 | -3% | -$17.3M |
|
48
Union Pacific
UNP
$133B
| $520M | 0.41% | 2,641,410 -88,300 | -3% | -$17.4M |
|
49
Linde
LIN
$224B
| $518M | 0.41% | 2,174,643 -66,100 | -3% | -$15.7M |
|
50
Qualcomm
QCOM
$173B
| $515M | 0.4% | 4,378,807 -141,800 | -3% | -$16.7M |
|